Abstract
Brucella cell surface protein (BCSP31) is potentially useful for diagnosing brucellosis. We aimed to establish a monoclonal antibody (MAb) against Brucella melitensis BCSP31 and to investigate its distribution in diagnosis. Soluble recombinant BCSP31 was successfully expressed and purified. Two MAbs (1F1 and 1E5) against B. melitensis BCSP31, effective in detecting both recombinant and cellular proteins, were obtained and characterized. The MAbs did not react with Escherichia coli, Staphylococcus aureus, Bacillus subtilis, Mycobacterium tuberculosis, or Bacillus aeruginosus, but strongly reacted with BCSP31 and B. melitensis by ELISA and Western blot analysis. We also tested different Brucella species and brucellosis using the prepared anti-BCSP31 MAbs. BCSP31 and anti-BCSP31 MAbs may play important roles in future research in diagnosing brucellosis.
Similar content being viewed by others
References
Akdeniz H, Irmak H, Anlar O et al (1998) Central nervous system brucellosis: presentation, diagnosis and treatment. J Infect 36:297–301
Franco MP, Mulder M, Gilman RH et al (2007) Human brucellosis. Lancet Infect Dis 7:775–786
World Health Organization (1997) Fact Sheet N173. World Health Organization, Geneva
Shang DQ (2004) Research on Brucella spp. Chin J Ctrl Endem Dis 19:204–213 (in Chinese)
Pappas G, Akritidis N, Bosilkovski M et al (2005) Brucellosis. N Engl J Med 352:2325–2336
Young EJ (1991) Serologic diagnosis of human brucellosis: analysis of 214 cases by agglutination tests and review of the literature. Rev Infect Dis 13:359–372
Vizcaino N, Cloekaert A, Zygmunt MS et al (1999) Molecular characterization of a Brucella species large DNA fragment deleted in B. abortus strains: evidence for a locus involved in the synthesis of a polysaccharide. Infect Immun 67:2700–2712
Ding JB, Mao KR, Chen XY et al (2006) Sequence analysis on BCSP31 genes of 8 different Brucella species. Chin J Vet Drug 40:13–16 (in Chinese)
Li P, Luo DY, Gao YH et al (2006) Construction of the recombinant expression plasmid BCSP31/pVAXl of Brucella and evaluation of its immuno-protective effect. Chin J Zoonoses 22:493–496 (in Chinese)
Davis DS, Elzer PH (2002) Brucella vaccines in wildlife. Vet Microbiol 90:533–544
Bricker BJ, Tabatabai LB, Deyoe BL et al (1988) Conservation of antigenicity in a 31-kDa Brucella protein. Vet Microbiol 18:313–325
Hasanjani Roushan MR, Mohrez M, Smailnejad Gangi SM (2004) Epidemiological features and clinical manifestations in 469 adult patients with brucellosis in Babol, Northern Iran. Epidemiol Infect 132:1109–1114
Madkour MM (2001) Difficulties in diagnosis and treatment. In: Madkour MM (ed) Brucellosis. Springer, Germany, pp 221–231
Yumuk Z, Afacan G, Caliskan S (2007) Relevance of autoantibody detection to the rapid diagnosis of brucellosis. Diagn Microbiol Infect Dis 58:271–273
Cloeckaert A, Vizcaíno N, Paquet JY et al (2002) Major outer membrane proteins of Brucella spp.: past, present and future. Vet Microbiol 20:229–247
Hoffmann F, Heuvel J, Zidek N et al (2004) Minimizing inclusion body formation during recombinant protein production in Escherichia coli at bench and pilot plant scale. Enzyme Microb Tech 34:235–241
Thakur MK, Ghosh S (2010) GST-tagged mouse estrogen receptor a-transactivation domain fusion protein is specifically degraded during its over-expression in E. coli and purification. Mol Biol Rep 37:1335–1340
Hayashi K, Kojima C (2008) pCold-GST vector: a novel cold-shock vector containing GST tag for soluble protein production. Protein Express Purif 62:120–127
Cai X, Wang JF, Wang YY et al (2010) Expression, purification and characterization of recombinant human interleukin-22 in Pichia pastoris. Mol Biol Rep 37:2609–2613
Song JP, Chen WT, Lu ZS et al (2011) Soluble expression, purification, and characterization of recombinant human flotillin-2 (reggie-1) in Escherichia coli. Mol Biol Rep. doi:10.1007/s11033-010-0335-4
Liu SX, Fu ZP, Mu RM et al (2010) Expression and characterization of Momordica Chanrantia anti-hyperglycaemic peptide in Escherichia coli. Mol Biol Rep 37:1781–1786
Cabrita LD, Bottomley SP (2004) Protein expression and refolding—a practical guide to getting the most out of inclusion bodies. Biotechnol Annu Rev 10:31–50
Tabatabai LB, Hennager SG (1994) Cattle serologically positive for Brucella abortus have antibodies to B. abortus Cu-Zn superoxide dismutase. Clin Diagn Lab Immunol 1:506–510
Kumar G, Rathore G, Sengupta U et al (2010) Production of monoclonal antibodies specific to major outer membrane protein of Edwardsiella tarda. Comp Immunol Microbiol Infect Dis 33:133–144
Zhang YQ, Li KN, Cui JH et al (2011) Abnormal expression of NRF-2a in hepatocellular carcinoma identified with a newly prepared monoclonal antibody against human NRF-2a protein. Mol Biol Rep. doi:10.1007/s11033-010-9976-6
Corbel MJ (1997) Brucellosis: an overview. Emerg Infect Dis 3:213–221
Xu WM, ** FZ, Su TK et al (2008) A dot-immunogold filtration assay to detect brucellosis in different areas. Chin Prev Med 9:681–682 (in Chinese)
Acknowledgments
We thank Professor Wenyu Ma, and Dr. Jun** Ren for their advice and assistance. Ailin Fan (**jng Hospital, **’an, China) and Jie Zhang (Center of Experiments, The Fourth Military Medical University) generously supplied the bacterial strains. This work was supported by grants from the Military Medical Science and Technique Foundation (No. 06G091) and National Natural Science Foundation of China (No. 30901281).
Author information
Authors and Affiliations
Corresponding authors
Additional information
Lei Zhang and **ng An Wu contributed equally to this work.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Zhang, L., Wu, X.A., Zhang, F.L. et al. Soluble expression and purification of Brucella cell surface protein (BCSP31) of Brucella melitensis and preparation of anti-BCSP31 monoclonal antibodies. Mol Biol Rep 39, 431–438 (2012). https://doi.org/10.1007/s11033-011-0755-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-011-0755-9